Finless Foods Inc.

Finless Foods Inc. , based in the US, is pioneering sustainable seafood production through cell-cultured technology, focusing primarily on tuna alternatives that promote ocean conservation and cater to health-conscious consumers. Founded in 2017 in Emeryville, US, Finless Foods Inc. develops cell-cultured seafood products, primarily tuna.

The company has completed 12 deals and raised a total of USD 34. 00 mn in its Series B funding round on March 2, 2022, led by Hanwha Solutions. Founders Brian Wyrwas and Michael Selden have a background in innovative food production, with Selden currently serving as the CEO. Finless Foods specializes in creating delicious, sustainable cell-cultured seafood products, focusing on tuna.

Their offerings are designed to meet the rising demand for seafood alternatives that do not rely on traditional fishing methods, thereby supporting ocean conservation. Utilizing advanced cell-cultured technology, the company produces seafood that replicates the taste and texture of conventional fish while reducing environmental impact. Their products target health-conscious and environmentally aware consumers across North America and select regions in Asia, providing innovative seafood alternatives to both retail consumers and food service establishments. Finless Foods generates revenue through direct sales of its cell-cultured seafood products to consumers and businesses in the food service industry.

Their transaction structure includes B2B and direct-to-consumer sales, establishing partnerships with restaurants, grocery stores, and specialty food retailers. The pricing structure accommodates individual sales and bulk purchasing agreements for larger clients, focusing on their flagship cell-cultured tuna products designed to appeal to environmentally conscious consumers and culinary professionals. In March 2022, Finless Foods raised USD 34. 00 mn in Series B funding to support several growth initiatives.

The company plans to introduce plant-based tuna nationally and expand its seafood portfolio while hiring additional staff. They will also pursue regulatory approval for their cell-cultured bluefin tuna to enhance market presence and reach broader consumer segments.